Methyl Palmitate-A suitable adjuvant for Sorafenib therapy to reduce in vivo toxicity and to enhance anti-cancer effects on hepatocellular carcinoma cells.

Breeta, Raja David Isac Evangeline; Grace, Viswanathan Mariammal Berlin; Wilson, Devarajan David

Breeta, Raja David Isac Evangeline; Grace, Viswanathan Mariammal Berlin; Wilson, Devarajan David.

Affiliation

Breeta RDIE; Department of Biotechnology, Karunya Institute of Technology and Sciences, Coimbatore, India.
Grace VMB; Department of Biotechnology, Karunya Institute of Technology and Sciences, Coimbatore, India.
Wilson DD; School of Science, Arts, Media and Management, Karunya Institute of Technology and Sciences, Coimbatore, India.

Basic Clin Pharmacol Toxicol ; 128(3): 366-378, 2021 Mar.

Article in En | MEDLINE | ID: mdl-33128309

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/pharmacology; Carcinoma, Hepatocellular/drug therapy; Liver Neoplasms/drug therapy; Palmitates/administration & dosage; Sorafenib/administration & dosage; Abnormalities, Drug-Induced/etiology; Angiogenesis Inhibitors/pharmacology; Animals; Apoptosis/drug effects; Cell Movement/drug effects; Hep G2 Cells; Humans; Palmitates/pharmacology; Palmitates/toxicity; Sorafenib/pharmacology; Sorafenib/toxicity; Zebrafish

Key words

HEP-G2 cells; Methyl Palmitate; Sorafenib; Zebrafish; anti-angiogenesis and teratogenic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Palmitates / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Hepatocellular / Sorafenib / Liver Neoplasms Type of study: Etiology_studies Language: En Journal: Basic Clin Pharmacol Toxicol Year: 2021 Type: Article Affiliation country: India

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google